World ADC Digital is the world’s premier online antibody drug conjugate event which focuses on giving attendees access to novel content and timely insight to help them stay ahead of the curve with the most cutting-edge ADC science.
We will also be presenting at the event. Our ADC Scientific Leader, Ian Glassford will be speaking on Wednesday 16th September 2020 at 2.30pm EDT on supporting integrated ADC design, development and manufacture. You can find out more here.
Ian’s presentation will cover:
- How design and developability assessments can help to select a successful ADC drug by identifying the right antibody, the right linker and the right payload combination using a truly integrated approach across a multidisciplined team.
- How using process development and GMP manufacturing capabilities of the highly potent payload, the linker, the antibody and the ADC, reduces the overall time to clinic by integrating multiple work streams to accelerate ADC production for IND submission.
- The benefits of applying Abzena’s pioneering flexible FTE model for example, de-risking the program by flexing the FTEs across Abzena’s full technical team to respond to data in real-time.
- Suitable case studies that demonstrate Abzena’s capabilities are presented/included.